Zhejiang Xianju PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Zhejiang Xianju PharmaceuticalLtd has a total shareholder equity of CN¥6.1B and total debt of CN¥101.2M, which brings its debt-to-equity ratio to 1.7%. Its total assets and total liabilities are CN¥6.9B and CN¥839.2M respectively. Zhejiang Xianju PharmaceuticalLtd's EBIT is CN¥680.4M making its interest coverage ratio -20.3. It has cash and short-term investments of CN¥1.3B.
Key information
1.7%
Debt to equity ratio
CN¥101.24m
Debt
Interest coverage ratio | -20.3x |
Cash | CN¥1.30b |
Equity | CN¥6.07b |
Total liabilities | CN¥839.16m |
Total assets | CN¥6.91b |
Recent financial health updates
Recent updates
Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Seems To Use Debt Quite Sensibly
Oct 16A Look At The Intrinsic Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)
Sep 03Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Will Pay A Dividend Of CN¥0.30
Jun 02Estimating The Fair Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)
Apr 15There Is A Reason Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Price Is Undemanding
Mar 05Financial Position Analysis
Short Term Liabilities: 002332's short term assets (CN¥3.2B) exceed its short term liabilities (CN¥737.7M).
Long Term Liabilities: 002332's short term assets (CN¥3.2B) exceed its long term liabilities (CN¥101.4M).
Debt to Equity History and Analysis
Debt Level: 002332 has more cash than its total debt.
Reducing Debt: 002332's debt to equity ratio has reduced from 63.7% to 1.7% over the past 5 years.
Debt Coverage: 002332's debt is well covered by operating cash flow (319.8%).
Interest Coverage: 002332 earns more interest than it pays, so coverage of interest payments is not a concern.